[Pediatrics. Upper limb treatment in congenital hemiparesis: progress and perspectives]

C J Newman1

  • 1Unité de neuropédiatrie et neuroréhabilitation pédiatrique, DMCP, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|February 12, 2011
PubMed

Insights

Congenital hemiparesis, a common pediatric motor disorder, is increasingly managed with advanced upper limb rehabilitation. Innovations include botulinum toxin injections and new therapies like constraint-induced movement therapy and robotic reeducation.

Area of Science:

  • Neurology
  • Pediatrics
  • Rehabilitation Medicine

Context:

  • Congenital hemiparesis represents a significant challenge in pediatric motor development.
  • The upper limb is frequently affected, impacting functional outcomes.
  • Recent advancements have transformed rehabilitation strategies.

Purpose:

  • To review the evolution of upper limb rehabilitation for congenital hemiparesis.
  • To highlight the impact of new therapeutic modalities.

Summary:

  • Focal chemical denervation using intramuscular botulinum toxin is a key innovation.
  • Novel techniques like constraint-induced movement therapy (CIMT) enhance motor recovery.
  • Robotic reeducation offers objective and intensive therapeutic interventions.

Impact:

  • These advancements offer improved functional outcomes for children with hemiparesis.
  • The integration of these techniques represents a paradigm shift in pediatric neurorehabilitation.
  • Further research continues to refine these effective treatment approaches.

Related Concept Videos